Dr. Henry Igid started medical school at age 16 and completed the accelerated program, with honors, when he was just 22. He was in the Philippines at the time and taking care of his grandfather, who eventually died of cancer.
“I then moved on to devote my time to becoming an oncologist and hematologist, and to provide the best care to each and every person with blood disorders and cancer that I treat,” Igid said.
Igid completed his internal medicine residency at the University of Connecticut and a three-year fellowship in hematology and oncology at Texas Tech University Health Sciences Center, where he served as chief fellow.
Now entering his second year with Comprehensive Cancer, he strives to understand how his patients’ lives are affected by their illness, so he can address their medical needs and expectations and offer the best care possible.
“I look forward to being a leader in bringing an integrated system for cancer care that is easy for patients to navigate,” Igid said. “It is a challenge, but I look forward to the day when treating cancer becomes an experience where patients don’t have to ‘lose.’”
Igid has a passion for equipping the next generation of physicians with the knowledge needed to succeed. He has served as a sub-investigator on several of Comprehensive’s clinical research trials, primarily focusing on lymphoma, leukemia and serious blood disorders, and spends time teaching anatomy to medical students and conducting lectures to help educate those with and without medical backgrounds about cancer.
Among his positions, Igid sits on Comprehensive’s pharmacy committee, helping to guide the practice’s stance on specific drugs and recommendations. Igid is also a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association and the Society of Clinical Research Associates.